Sign in

NCT04479475Completed

Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania

Understanding the Role of Social Networks in Methadone Maintenance Treatment Retention and Antiretroviral Therapy Adherence Among People Who Inject Drugs in Tanzania

Source: ClinicalTrials.gov · Last updated 8 Oct 2025

Brief summary (registry, in English)

Investigators will adapt the Brief Social Behaviour and Network Therapy (B-SBNT) intervention developed to facilitate recovery among people receiving medication-assisted treatment for opioid use disorder in the United Kingdom. The B-SBNT involves families and the wider social networks of people receiving medications for opioid use disorder to support recovery. Key components of the intervention include: mapping the social networks of clients; inviting others identified through the mapping to participate in the intervention; building communication strategies with network members; and developing joint activities with network members. In the original B-SBNT, the intervention is delivered by therapists/clinicians who undergo training. Investigators will pilot test the adapted version of this intervention with a maximum of 80 people: 20 current clients receiving methadone maintenance treatment (MMT) at the Muhimbili National Hospital (MNH) Medically-Assisted Treatment (MAT) Clinic and up to 60 social support persons identified by recruited MMT clients. The pilot will assess the social network intervention's acceptability and feasibility.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
13 Jul 2020
Start date
1 Mar 2024
Primary completion date
5 Sept 2024
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Diseases
HIV
NCT number
NCT04479475

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 1 Mar 2024 to the primary completion date, 5 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Does not meet inclusion criteria

Who the study is looking for

  • 18 years old or older,
  • currently enrolled in the MAT program at the Muhimbili MAT clinic,
  • prescribed methadone for the past 3 months,
  • received a positive test result for heroin, cannabis or alcohol use in the past 3 months,
  • provide consent for trial participation.
  • 18 years old or older,
  • identified as a social support person of a MMT client participating in the pilot trial
  • lives in Dar es Salaam,
  • provide consent for trial participation.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Muhimbili National Hospital
Coordinator of this site? Confirm its status
Dar es SalaamTanzaniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.